Delphinus Medical Technologies has submitted an application with the FDA for its SoftVue system, a 3D imaging device that could provide doctors with a safer and more precise alternative to mammograms in diagnosing breast cancer. CEO William Greenway said he hopes the company will get an FDA OK to begin marketing the device during the first half of 2013.
Delphinus pursues FDA OK for breast cancer device
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan